54 related articles for article (PubMed ID: 3248518)
1. [Comparison of the efficacy of intravenous urokinase and defibrase on 6-hour-old canine coronary thrombosis].
Huang DX; Song AL; Yang XS
Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Dec; 16(6):363-5, 384. PubMed ID: 3248518
[No Abstract] [Full Text] [Related]
2. Comparison of the thrombolytic efficacy of defibrase and urokinase on canine coronary artery thrombosis and the mechanism of urokinase-induced hemorrhage.
Huang DX; Song A; Yang X; Wang S
Acta Cardiol; 1987; 42(4):249-61. PubMed ID: 3499037
[TBL] [Abstract][Full Text] [Related]
3. [Effects of intracoronary or intravenous urokinase on canine coronary thrombosis].
Song AL
Zhonghua Yi Xue Za Zhi; 1987 Dec; 67(12):668-70. PubMed ID: 3130159
[No Abstract] [Full Text] [Related]
4. Preventive effects of batroxobin on experimental canine coronary thrombosis.
Tomaru T; Uchida Y; Sonoki H; Sugimoto T
Clin Cardiol; 1988 Apr; 11(4):223-30. PubMed ID: 3163298
[TBL] [Abstract][Full Text] [Related]
5. Thrombolysis with recombinant human single-chain urokinase-type plasminogen activator (rscu-PA): dose-response in dogs with coronary artery thrombosis.
Van de Werf F; Jang IK; Collen D
J Cardiovasc Pharmacol; 1987 Jan; 9(1):91-3. PubMed ID: 2434801
[TBL] [Abstract][Full Text] [Related]
6. Enhanced myocardial salvage by combined treatment with recombinant single-chain urokinase-type plasminogen activator and recombinant human superoxide dismutase in a canine coronary thrombosis model.
Fincke U; Schneider J; Friderichs E; Giertz H; Flohé L
Arzneimittelforschung; 1988 Jan; 38(1):138-42. PubMed ID: 3365272
[TBL] [Abstract][Full Text] [Related]
7. [Increased fibrinolytic activity by sequential treatment with defibrase-plasminogen-urokinase in pulmonary embolism and deep venous thrombosis].
Brochier M; Griguer P; Raynaud P; Fauchier JP; Charbonnier B
Arch Mal Coeur Vaiss; 1981 Jul; 74(7):761-9. PubMed ID: 6794497
[No Abstract] [Full Text] [Related]
8. [Coronary thrombolysis by t-PA and pro-UK].
Kanmatsuse K; Suzuki T; Kajiwara N
Nihon Rinsho; 1989 Apr; 47(4):910-6. PubMed ID: 2501541
[No Abstract] [Full Text] [Related]
9. [Late effect of intracoronary urokinase. Apropos of a case of recurrent coronary thrombosis after angioplasty].
Guenot O; Cristofini P; Desnos M; Hagège A
Arch Mal Coeur Vaiss; 1988 Mar; 81(3):335-8. PubMed ID: 2969226
[TBL] [Abstract][Full Text] [Related]
10. Tissue-type plasminogen activator for acute coronary thrombosis.
Med Lett Drugs Ther; 1987 Dec; 29(754):107-9. PubMed ID: 3119965
[No Abstract] [Full Text] [Related]
11. [Comparison of defibrase and heparin in the prevention of thrombosis after coronary intervention].
Xiang D; Huang D; Ge L
Zhonghua Nei Ke Za Zhi; 1997 Dec; 36(12):799-801. PubMed ID: 10451932
[TBL] [Abstract][Full Text] [Related]
12. Treatment of right atrial thrombus with urokinase.
Goldhaber SZ; Nagel JS; Théard M; Levine JD; Sutton MG
Am Heart J; 1988 Apr; 115(4):894-7. PubMed ID: 3354417
[No Abstract] [Full Text] [Related]
13. [Thrombolytic agents].
Furukawa K
Nihon Geka Gakkai Zasshi; 1984 Sep; 85(9):1166-9. PubMed ID: 6503980
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of arterial thrombolysis with native tissue type plasminogen activator by pretreatment with heparin or batroxobin: an angioscopic study.
Tomaru T; Uchida Y; Nakamura F; Sonoki H; Tsukamoto M; Sugimoto T
Am Heart J; 1989 Feb; 117(2):275-81. PubMed ID: 2492737
[TBL] [Abstract][Full Text] [Related]
15. [New methods of thrombolysis].
Vinazzer H
Wien Med Wochenschr; 1987 Jun; 137(10-11):221-4. PubMed ID: 2955574
[TBL] [Abstract][Full Text] [Related]
16. [Pathophysiology and treatment of thrombosis. 3. Prevention and treatment of thrombosis. (1) The role of intracoronary thrombi, platelet function and prostaglandins in the pathogenesis of myocardial infarction; with special reference to intracoronary thrombolysis treatment].
Kawai C; Yui Y
Nihon Naika Gakkai Zasshi; 1987 Jan; 76(1):43-8. PubMed ID: 3553380
[No Abstract] [Full Text] [Related]
17. [The beneficial effects of intravenous bolus injection of urokinase followed by conventional selective intracoronary thrombolysis].
Yahagi T; Araki T; Miura T; Goto T; Saito H; Ohyama T; Matsui M; Suzuki M; Saito M; Yokoyama K
Kokyu To Junkan; 1988 May; 36(5):517-23. PubMed ID: 3413353
[No Abstract] [Full Text] [Related]
18. [Multicentre clinical observation of anticoagulation and thrombolysis for the deep venous thrombosis].
Wang HT; Jiang WL; Zhang YN; Sun ZF; Sun QF; Ma J
Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(45):3181-5. PubMed ID: 20193529
[TBL] [Abstract][Full Text] [Related]
19. Additional myocardial salvage by coadministration of the epoprostenol analog taprostene to recombinant single-chain urokinase-type plasminogen activator in a canine coronary thrombosis model.
Groves R; Schneider J; Friderichs E; Giertz H; Flohé L
Arzneimittelforschung; 1989 Apr; 39(4):534-8. PubMed ID: 2665759
[TBL] [Abstract][Full Text] [Related]
20. Accelerated intravenous dosing of recombinant tissue-type plasminogen activator causes rapid but unstable reperfusion in a canine model of acute myocardial infarction.
Gurbel PA; Anderson RD; MacCord CS; Scott H; Serebruany V; Herzog WR
Coron Artery Dis; 1994 Nov; 5(11):929-36. PubMed ID: 7719525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
